| |
| |
|
| Insider
Information: |
Cooke Michael P. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
240,523 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$168,270 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
240,523 |
|
|
| Total
Value |
$168,270 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dianthus Therapeutics Ord Shs |
DNTH |
|
2019-12-02 |
240,523 |
2018-06-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2019-12-02 |
4 |
S |
$12.74 |
$97,520 |
D/D |
(7,500) |
240,523 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2019-11-20 |
4 |
S |
$12.00 |
$60,000 |
D/D |
(5,000) |
248,023 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2019-11-01 |
4 |
S |
$10.67 |
$53,334 |
D/D |
(5,000) |
253,023 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2019-10-01 |
4 |
S |
$10.01 |
$50,064 |
D/D |
(5,000) |
258,023 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2019-09-19 |
4 |
AS |
$12.00 |
$19,872 |
D/D |
(1,656) |
263,023 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2019-09-12 |
4 |
AS |
$12.00 |
$10,128 |
D/D |
(844) |
264,679 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2019-09-03 |
4 |
AS |
$10.11 |
$50,531 |
D/D |
(5,000) |
265,523 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2019-08-01 |
4 |
AS |
$13.41 |
$100,631 |
D/D |
(7,500) |
270,523 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2019-07-01 |
4 |
AS |
$14.39 |
$107,983 |
D/D |
(7,500) |
278,023 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2019-06-17 |
4 |
AS |
$13.90 |
$104,267 |
D/D |
(7,500) |
285,523 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
Chief Scientific Officer |
• – – |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,370 |
293,023 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
